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Abstract
Background: This paper presents the pilot study and protocol for a randomised controlled trial
to test the effectiveness of a psychological, family-based intervention to improve outcomes in those
with poorly controlled type 2 diabetes. The intervention has been designed to change the illness
perceptions of patients with poorly controlled type 2 diabetes, and their family members. It is a
complex psychological intervention, developed from the Self-Regulatory Model of Illness
Behaviour. The important influence the family context can have in psychological interventions and
diabetes management is also recognised, by the inclusion of patients' family members.
Methods/design: We aim to recruit 122 patients with persistently poorly controlled diabetes.
Patients are deemed to have persistent poor control when at least two out of their last three
HbA1c readings are 8.0% or over. Patients nominate a family member to participate with them, and
this patient/family member dyad is randomly allocated to either the intervention or control group.
Participants in the control group receive their usual care. Participants in the intervention group
participate, with their family members, in three intervention sessions. Sessions one and two are
delivered in the participant's home by a health psychologist. Session one takes place approximately
one week after session two, with the third session, a follow-up telephone call, one week later. The
intervention is based upon clarifying the illness perceptions of both the patient and the family
member, examining how they influence self-management behaviours, improving the degree of
similarity of patient and family member perceptions in a positive direction and developing
personalized action plans to improve diabetes management.
Discussion: This study is the first of its kind to incorporate the evidence from illness perceptions
research into developing and applying an intervention for people with poorly controlled diabetes
and their families. This study also acknowledges the important role of family members in effective
diabetes care. 
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The importance of glycaemic control
A large body of evidence is now available showing that
good glycaemic control in diabetes (as assessed by
HbA1c) is associated with improved outcomes [1-6]. Cur-
rent international guidelines recommend a HbA1c target
level of approximately 6.0%–7.5% [7-9]. However,
achieving good glycaemic control requires patients to fol-
low a treatment regime which involves lifelong behav-
ioural self-regulation through lifestyle changes (e.g. diet,
exercise) and self-management skills (monitoring symp-
toms, testing blood glucose, taking medication). Many
patients can have difficulties following this treatment
regime[10,11] and evidence suggests only about one-third
of patients with type 2 diabetes achieve glycaemic targets
[12]. This has led to a call for concerted efforts to increase
the proportion of patients achieving good glycaemic con-
trol [12]. It would seem prudent then, for interventions
aiming to improve outcomes in diabetes, to be particu-
larly aimed at patients having difficulties controlling their
illness.
Psychological interventions
There is growing awareness of the important role of psy-
chosocial and behavioural factors in diabetes manage-
ment [10], as highlighted by recommendations to
integrate psychosocial support into routine diabetes care
[8,13]. Psychological interventions to improve outcomes
in diabetes have been systematically reviewed by a
number of different authors, [14-16], with pooled trial
results suggesting psychological interventions in diabetes
reduce HbA1c by a clinically significant 1% [17]. Psycho-
social interventions targeting those in poor control of
their diabetes have been successful in improving glycae-
mic control in patients with type 1 diabetes [18-20], how-
ever there appear to be few interventions targeting those
with poorly controlled type 2 diabetes.
Illness perceptions
One psychological approach that has been widely used in
diabetes research is based on the Self-Regulatory Model of
Illness Behaviour [21,22]. This approach proposes that in
response to an illness, or health threat, people form their
own common sense beliefs or illness perceptions about
their illness and treatment. (The terms 'illness percep-
tions', 'illness representations', 'illness cognitions', and
'illness beliefs' are often used interchangeably in the liter-
ature; here the term illness perceptions is used.) These ill-
ness perceptions influence the types of health-related
behaviours and coping behaviours which a patient uses
for managing their illness and which may impact on dis-
ease outcomes. Research into illness perceptions [23,24]
suggests they encompass five broad dimensions: identity,
timeline, causes, consequences, and curability/controlla-
bility (see Figure 1: the five domains of illness percep-
tions). Patients' perceptions of their diabetes have been
found to influence self-management behaviours [25-30]
which may, in turn, impact on glycaemic control [31,32].
Patients in poor control of their diabetes have been found
to have distinctly different perceptions of their illness
than those in good control. A study of patients with type
2 diabetes [33] found that compared to patients in good
control (HbA1c < 7), those in poor control (HbA1c > 8.5)
had a stronger perception that their illness was caused by
hereditary factors, reported suffering from more diabetes-
related symptoms, perceived diabetes as having signifi-
cantly greater impact on their lives, and reported more
negative emotions in relation to their illness. Interven-
tions focusing on changing these illness perceptions
amongst patients in poor control may lead to improved
illness outcomes, including better glycaemic control. A
brief intervention (3 sessions)[34] designed to alter
patients' perceptions about their recent MI was associated
with significant positive changes in patients perceptions
of their illness, as well as a significantly earlier return to
work and lower rates of angina symptoms. However, there
would appear to be few interventions which attempt to
improve outcomes by explicitly targeting and measuring
changes in illness perceptions in of type 2 diabetes.
The role of the family
A comprehensive understanding of how people think
about, and thus manage, their illness can only be reached
by taking into account the social and family context in
which the thoughts were developed [35]. The possible
impact of the family context on illness perceptions is par-
ticularly relevant for diabetes, as most of the self-regula-
tory behaviours involved in the self-management of
diabetes occur at home. Evidence from a small number of
studies suggests that the illness perceptions of family
members may influence disease outcomes. Differences
between the illness perceptions of patients with chronic
The five domains of illness perceptions [21]Figure 1
The five domains of illness perceptions [21].
Identity 
(label) 
Timeline Consequences Cause Control 
Symptoms 
Names 
Expected 
duration 
Impact on life 
functioning 
External  
(e.g. infection) 
Internal  
(e.g. genes) 
Preventable 
Curable 
Controllable 
Situational stimuli 
about health 
threat/illness 
Inter/outer 
Perceptions of 
illness/health 
threat 
Coping Procedures
Action Plans 
Appraisal Page 2 of 10
(page number not for citation purposes)
BMC Family Practice 2007, 8:36 http://www.biomedcentral.com/1471-2296/8/36illness and their spouses have been found to have a strong
impact on patients' adaptive outcomes [36], while similar
positive patient and spouse perceptions about the identity
and consequences of MI have been found to be associated
with better physical, psychological, social and sexual func-
tioning [37]. Substantial differences have been found
between family members' and patients' perceptions of
type 2 diabetes [38]. Family members perceived diabetes
as a more serious illness, and as having a greater impact
on daily life, than those with the illness. Those with dia-
betes were unaware of their family member's heighten
concerns and had a more relaxed approach to living with
diabetes. Interventions targeting the illness perceptions of
patients and families would seem a promising area for
future research in view of the evidence suggesting that the
degree of congruence between patient and spouse illness
perceptions is related to illness outcomes. A hypothesised
model by which family members illness perceptions may
influence patient health outcomes in diabetes is presented
in figure 2. (Figure 2: how family members may influence
outcomes in diabetes.)
Family interventions in type 2 diabetes
A number of authors have noted that the role of family
factors in adult diabetes intervention research has been
neglected, particularly in type 2 diabetes. [10,39-41] This
is despite recent evidence suggesting that the inclusion of
a family member in psychosocial interventions for
chronic illness may improve illness outcomes [42-45] A
recent systematic review [46 Zhang & Fisher, 2005 #516]
identified only one published RCTs that included a
patient's family member in an intervention for patients
with type 2 diabetes [47]. This study [47] was based on a
behavioural weight loss intervention, which included
patients' spouses. The study found a significant weight
loss in both control and family group. However, there was
a significant interaction of treatment and gender, with
women doing better than men when treated with their
spouses as opposed to being treated alone.
This paper presents the pilot study and the protocol for a
RCT that is currently underway to test the effectiveness of
a family-based intervention, designed to change the ill-
ness perceptions of patients with poorly controlled type 2
diabetes and their family members.
Trial objectives
• To examine the effects of a psychological, family-based
intervention to improve biophysical, psychosocial and
behavioural outcomes for patients with poorly controlled
type 2 diabetes.
• To evaluate the experience of participating in the inter-
vention.
Methods/design
This study is a randomised controlled trial. In order to
recruit a sufficiently large sample of patients with poorly
controlled diabetes, participants are being recruited from
diabetes specialist clinics, rather than from a primary care
setting. In Ireland, the majority of patient's with type 2
diabetes in poor control of their illness are referred by
their GP to a specialist clinic, and are mainly managed
there. Thus, it would not have been possible to recruit the
required number of participants in poor control of their
diabetes from a primary care setting.
Participants
There will be two groups of participants in the study;
patients with poorly controlled type 2 diabetes and their
family members. A record will be kept of all clinic attend-
ees who do not wish to participate and their reasons for
non-participation. Participants and non-participants will
be compared across a number of variables (e.g. age, gen-
der etc) to investigate any sub-group differences.
Inclusion and exclusion criteria
People with poorly controlled type 2 diabetes
People with type 2 diabetes are included in the trial if they
are over 18 years of age, have fluency in English, have type
2 diabetes for more than one year, and at least two out of
their last three HbA1c readings haven been 8.0% or over,
in order to identify patients' with persistent poor control.
(A HbA1C reading of 8% or over is a recognised value for
poor metabolic control of diabetes [48].) Patients with a
life-threatening physical illness (e.g. cancer, renal failure)
will be excluded. Patients with a severe and enduring
mental disorder (e.g. dementia, schizophrenia) as deter-
mined by the patients' clinician, will also be excluded.
Patients not responsible for their own care, or those not
residing in their home environment will be excluded (e.g.
those in care homes, prison, in-patient hospital wards).
How family members may influence outcomes in diabetesFigure 2
How family members may influence outcomes in diabetes.
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Flow Chart of RCTigure 3
Flow Chart of RCT.
WEEK 1   
    
WEEK 10   
WEEK 11-18      
   
       
           
                                 
WEEK 35-42   
PROCESS 
EVALUATION
DIARY
BASELINE DATA COLLECTION
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Recruitment will be staggered into three blocks of 40 participants 
each, to allow for recruitment to continue while the intervention is 
being delivered. It is estimated it will take approx. 10 weeks to recruit 
the each  block of 40 participants.
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6 MONTH FOLLOW-UP DATA COLLECTION
• Diabetes Outpatients Clinic; 6-month follow-up appointment.       
• Follow-up biomedical tests taken and questionnaires completed  
Participants in both the intervention and control groupss will be invited 
back to the clinic in the same staggered manner they were recruited for  
follow-up data collection. The 6month period is calculated as being 
approximately 24 weeks from the time of randomisation.
BMC Family Practice 2007, 8:36 http://www.biomedcentral.com/1471-2296/8/36Patients with hearing impairments will also be excluded.
Patients who took part in the pilot study, and those who
took part in a previous study conducted in the same dia-
betes clinic [33]will be excluded.
Family members of participants with type 2 diabetes
Participants with poorly controlled type 2 diabetes
recruited to the study will be asked to nominate a family
member to participate in the research with them. For the
purposes of this study family members will be defined as
any relative in regular contact with the person with diabe-
tes, and who is most involved in supporting that person
in the management of their illness. As most people with
diabetes manage their illness themselves, the family mem-
ber for this study is not a carer, but someone with whom
the person with diabetes has a close relationship. This
may include a spouse/partner, parent, grandparent, child,
grandchild, siblings, or other family members. The inclu-
sion criteria for a family member are that they must be
over 18 years of age and have no medical history of type 1
or type 2 diabetes.
Screening eligibility
Potential participants will be recruited from two diabetes
specialist clinics at the AMNCH Hospital in Tallaght in
Dublin. All type 2 patients over 18 years, with at least two
of their last three HbA1c readings of 8.0% or greater (eli-
gible participants), will be identified through the auditing
facility of the "Diamond" computer database (n~ 3560
type 2). Prior to each clinic a list of eligible patients
attending the clinic will be generated by the Diamond
database, who will subsequently be asked to participate in
the study (see Figure 3: Flowchart of RCT).
Baseline assessment
During the twice-weekly out-patients clinics eligible
patients will be approached by the researcher, given infor-
mation about the study and invited to participate. On
agreement, they will be asked provide their written
informed consent, and to complete the baseline question-
naires with the researcher (this will take on average fifteen
minutes). These questionnaires consist of demographic
questions, the brief-illness perceptions questionnaire
[49], the well-being 12 scale [50], the diabetes manage-
ment self-efficacy scale [51], the diabetes family behav-
iour checklist [52]and the summary of diabetes self-care
daily activities [53]). At this appointment time their
HbA1c, blood pressure, and body-mass index will also be
taken. The person with diabetes will also be given a ques-
tionnaire pack containing the family member measures,
and asked to ensure their nominated family member com-
pletes the questionnaires and returns them by post to the
researcher, prior to commencement of the intervention.
The family member questionnaire include demographic
questions, and adapted versions of the brief illness per-
ceptions questionnaire [49]and the diabetes family
behaviour checklist [52].
Outcome assessment
At six months post-intervention (approximately 24 weeks
from the time of randomisation), control and interven-
tion participants will be invited back to the diabetes clinic
in the same staggered manner as they were recruited. At
this time point, HbA1c, blood pressure, cholesterol and
body-mass index will be taken again and recorded. The
baseline questionnaires will also be re-administered. In
addition, a record will be kept of participation rates
throughout the intervention and reasons for non-partici-
pation where possible. Participants will again be given a
questionnaire pack containing the family member meas-
ures, and asked to ensure that their nominated family
member completes the questionnaires and returns them
to the researcher by post.
Randomisation
After consent and baseline data have been collected from
the first 40 patients, they will be randomized into inter-
vention and control groups by using computer generated
Table 1: Sample case study for intervention
FC, male mid 50's, with poorly controlled type 2 diabetes. He says he understands very little about his diabetes (illness coherence), but that he feels 
it has a huge impact on his life e.g. he hates taking the medication, he is tired all the time etc (consequences). FC doesn't believe lifestyle factors are 
important in controlling his illness (control), because he believes the causes of the illness are purely genetic (he believes he inherited the illness from 
his mother – causal). His wife, MC, believes that while she does not understand the diabetes, her husband understands his diabetes very well 
(coherence), but that it has very little impact or effect on his life (consequences); She also thinks that he is over-reacting when he complains about 
it. She believes his diabetes was caused by stress (cause), and if he stopped working so much and took more time to relax, his condition would 
improve (control). She also does not recognise the importance of lifestyle factors such as diet and exercise for controlling diabetes (control), 
because she thinks the illness is stress-related and continues to prepare high-fat, high-sugar meals for her husband.
The intervention sessions with this couple could be tailored to focus on clarifying the causal dimension of illness perceptions of both participants, by 
focusing on the risk factors associated with developing type 2 diabetes. In particular, the importance of lifestyle factors in controlling the illness 
could be emphasised, and attempts to improve the patient's level of personal control over the illness. The intervention could also focus on 
highlighting and resolving differences between the patient's and family member's illness perceptions, such as the discrepancy between the perceived 
consequences and levels of understanding between the patient and his wife. A written, personalised action plan to improve control of the patient's 
diabetes could then be developed in collaboration with the patient and his wife. This could include, for example, an agreement for the patient and 
his wife to take time to go out walking together three times a week, to reduce the levels of fatty and sugary foods consumed etc.Page 5 of 10
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involved in the randomisation procedure, which will be
carried out by an independent expert. The use of block
randomisation means that the intervention can be deliv-
ered in a staggered manner, with some participants begin-
ning the intervention while further recruitment continues.
When the next 40 patients are recruited, they will then be
randomly allocated to intervention or control groups, and
so on, until 122 patients are included in the trial. Due to
the psychological nature of the intervention, it is not pos-
sible for the investigator delivering the intervention to be
blind to participants' treatment allocation group.
Intervention
The intervention is a complex psychological intervention
designed to change the illness perceptions of patients with
type 2 diabetes and their family members. The starting
point for the intervention is the illness perceptions mod-
els of diabetes held by the patient and the family member
and the degree of similarity between these models. The
intervention is based upon clarifying the five illness per-
ception dimensions of both the patient and the family
member in relation to diabetes, examining how they
influence self-management behaviours, and developing
personalized action plans. The intervention will be tai-
lored to each individual patient and family member; thus,
the exact content of each session will depend upon the
individual illness perceptions of the patient and family
member, and the degree of congruency between these per-
ceptions. In essence, the intervention is designed to
change any inaccurate and/or negative illness perceptions
which the patient or family member may have, and
improve the degree of congruence of patient and family
member perceptions, in a positive direction. A sample
case study is presented in Table 1 to illustrate how the
intervention might work (Table 1: sample case study for
intervention). A more detailed description of the interven-
tion can be found in the intervention manual (see addi-
tional file 1)
The intervention that is the focus of this study is relatively
brief, in view of recent research suggesting that briefer psy-
chosocial interventions can be more easily integrated into
routine care. Due to the brief nature of the intervention
and its emphasis on behaviour change, techniques from
brief motivational interviewing [54] will be used to
deliver the intervention. These techniques have been suc-
cessfully used in other brief interventions of this type
[55,56]. The intervention will consist of three sessions
delivered on a weekly basis, the first two of which will take
place in the patient's home with their family member, and
the last one of which consists of a phone call to the person
with diabetes. Sessions will be delivered by a health psy-
chologist who is trained in motivational interviewing
techniques. Each session will last approximately 40 min-
utes.
Sample size and rate of recruitment
Taking HbA1c and Diabetes Well-being as primary out-
comes, a total sample size of 76 and 86 respectively, were
calculated. This was using 80% power to detect a signifi-
cant absolute change of 0.9% in glycaemic control (this
Table 2: Process evaluation components
Process Evaluation Questions Data Collection Tool Source Trial Stage
Implementation
Was the intervention properly 
delivered?
Treatment fidelity to different 
components.
Monitor dose/participant 
exposure to intervention 
components
1.10% of sessions randomly 
selected to be taped and analysed 
by independent expert in illness 
perceptions and motivational 
interviewing.
Tapes analysed qualitatively and 
quantitatively using MI & IP 
checklists.
Randomly selected sub-sample of 
intervention participant's.
Collecting during intervention 
delivery.
Analysed post-intervention
Receipt
1.Participants views of the 
intervention and partaking in 
the RCT.
1.Open-ended questionnaires for 
all participants in control and 
intervention groups
1. All participants 1. Collected at follow-up data 
collection
2.Appropriateness of use of 
intervention and techniques 
for type 2 diabetes
2. Focus groups with sub-sample of 
intervention participants
2. Sub-sample of intervention 
participant's.
2. Collection post-follow-up
Contextual factors
What was the effect of various 
setting/contextual factors. e.g. 
interruptions during session, 
family dynamic, mood, etc.
Structured field notes 
questionnaire (e.g. how long each 
session, where in home delivered, 
interruptions, dynamic, etc)
Interventionist Collecting during intervention 
delivery.
Analysed post-intervention
Sub-groups variations (e.g. 
family member involved)
Interventionist observations – field 
diaryPage 6 of 10
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the UK prospective diabetes study, [3] and of 3 points in
the Diabetes Well-being Scale-12. These calculations also
allow for an anticipated "Hawthorn effect" relating to an
improvement of 20% for those in the control group, by
virtue of the fact that they are participating in the research.
Taking the larger number of86 participants (43 ininter-
vention and 43 in control group), a final total number of
122 participants (61 in each group) is needed to ensure at
least a 70% final response rate is met. Previous research in
the diabetes clinic [33] has shown that it is possible for
one researcher to see approximately two to three eligible
patients per clinic. Thus, it is estimated that it will take
approximately 8–10 weeks to recruit the required 40 par-
ticipants for the first block for randomisation.
Qualitative component
Participants with type 2 diabetes (in the intervention
group only) will be asked to complete a brief diary on a
weekly basis for the first six weeks and every second week
for the remaining eighteen weeks. Diaries will be struc-
tured to allow for the examination of the intervention and
the process of change over time. In order to maximize
compliance to filling in the diary, weekly/fornightly text
messages will be sent to remind participants to fill in their
diary. A computer program will be used to send text mes-
sages to a large number of mobile phones at regular inter-
vals.
Quality assurance
The process evaluation component of this RCT will run
alongside data collection and intervention delivery. The
use of both qualitative and quantitative data provides the
strongest evidence for process evaluation [57,58]. There-
fore, qualitative and quantitative process evaluation data
will be collected in this study, focusing on aspects of inter-
vention implementation, participant experience of receipt
of the intervention, and the influence of contextual/set-
ting factors. See Table 2 for an outline of the process eval-
uation questions and data collection tools (Table 2:
process evaluation components).
Analysis
Quantitative analysis
SPSS Version 13.01 for Windows will be used in the anal-
ysis. Differences in biomedical, psychosocial and illness-
specific outcomes between the intervention and control
group will be analyzed for the two time-points (baseline
and 6 months post- intervention). Further statistical anal-
ysis will be based on repeated measures analysis of vari-
ance. Statistical significance will be taken at the 5% level
for primary outcomes, and at 1% level for secondary out-
comes.
Qualitative analysis
Qualitative data will be analysed using phenomenologi-
cal techniques. Both content analysis and thematic analy-
sis will be applied to the data
Trial organisation and management
The trial is being managed by the Department of Public
Health and Primary Care, Trinity College Dublin, and the
Diabetes Centre, Adelaide and Meath incorporating the
National Children's Hospital, Tallaght, Dublin. Ethical
approval was obtained from the Joint Research Ethics
Committee of St. James's Hospital and the Federated Dub-
lin Voluntary Hospitals
Pilot study
Participants for the pilot study were recruited from six
weekly clinics in the Diabetes Centre, during the summer
of 2006. Twelve eligible patients agreed to participate in
the pilot and completed baseline assessment. Participants
were divided into intervention and control groupss; six in
the intervention and six in the control. Two participants in
the intervention group, and one from the control group,
withdrew from the study, leaving nine participants in the
pilot study, four of which completed the intervention ses-
sions. Pilot participants were not recalled for outcome
assessment, since the small sample size would not allow
for statistical analysis. A flow-chart of the recruitment
process for the pilot study is shown in figure. 4 (Figure 4:
Flowchart of recruitment of pilot participants).
Flowchart of recruitment of pilot participantsigure 4
Flowchart of recruitment of pilot participants.
Total number attending 
six clinics - 159 
45 eligible 
14 DNA 
31 attended 
17 refused 
29 invited to 
participate 
12 participate 
RANDOMISATION 
6 
intervention 
group 
6 control group 3 family 
members 
return 
questionnaires 
Intervention 
delivered to 4 
participants 
(2 withdrew)  
5 family 
members 
return 
questionnaires Page 7 of 10
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and delivery of the intervention worked well and recruit-
ment began for the main study in October 2006. How-
ever, following the pilot study, it was considered necessary
to change one of the measures to be used in the RCT. Fol-
lowing feedback from some of the participants showing
that the original self-efficacy measure was quite difficult
for them to understand; this measure was replaced by the
Diabetes Management Self-Efficacy Scale[51]. The rate of
recruitment for the pilot was also slower than anticipated.
To ensure sufficient numbers of participants were
recruited for the main trial, it was decided it would be nec-
essary to recruit participants for the main trial from an
additional weekly clinic.
Discussion
This trial aims to assess the effectiveness of a family-based,
psychological intervention to improve outcomes in those
with poorly-controlled type 2 diabetes. The intervention
recognises the important role of family members in effec-
tive diabetes care, and it is the first of its kind to adapt evi-
dence from the illness perceptions research to an
intervention for people with poorly-controlled diabetes
and their families.
The intervention is based on a clearly specified theoretical
framework; Leventhal's Self-Regulatory Model of Illness
Behaviour [21,22]. There is much empirical evidence
showing that the concepts of this model are related to ill-
ness outcomes in diabetes, and illness perception inter-
ventions in various disease populations have also been
successful in changing illness perceptions and improving
illness outcomes [34].
The study is further located within three main theoretical
frameworks outlined by Matire and colleagues [44],
including the bio-psychosocial model e.g. [59], martial
and family system framework e.g[60], and family care-giv-
ing and receiving model e.g. [61], with some evidence to
suggest family members own illness perceptions of the
patients illness can influence outcomes. It has been pro-
posed that family members may influence outcomes in
physical health by means of a psychophysiological and/or
health behaviour pathway, [42,43]. This intervention tar-
gets both of these pathways insofar as it attempts to
change negative illness perceptions and increase the
degree of similarity of patient and family member percep-
tions. These may in turn directly impact upon self-man-
agement behaviours (e.g. through increased self-efficacy,
support for diabetes-specific activities), and indirectly
improve the nature and quality of family functioning and
interactions (e.g. through increased understanding, more
general support).
This trial includes a combination of both process indica-
tors and outcome measures as recommended by a
number of authors [57,58,62], The process evaluation
component will provide detailed information on how the
intervention was delivered and received, which will allow
for increased generalisability of results, whilst also ensur-
ing quality through the assessment of treatment fidelity. A
primary aim of the process evaluation is to establish why
the intervention achieved its results. Thus, if the interven-
tion has little or no impact on outcomes, the process eval-
uation data should uncover whether this was due to
inadequate design (a failure of concept/theory), poor
delivery (implementation failure) and/or or other factors.
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